These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11404035)

  • 21. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies.
    Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH
    Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of Octastatin, a somatostatin analog cyclic octapeptide, in aqueous solution.
    Jang SW; Woo BH; Lee JT; Moon SC; Lee KC; DeLuca PP
    Pharm Dev Technol; 1997 Nov; 2(4):409-14. PubMed ID: 9552470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formation of amide- and imide-linked degradation products between the peptide drug oxytocin and citrate in citrate-buffered formulations.
    Poole RA; Kasper PT; Jiskoot W
    J Pharm Sci; 2011 Jul; 100(7):3018-22. PubMed ID: 21547912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fundamental analysis of recombinant human epidermal growth factor in solution with biophysical methods.
    Kim NA; Lim DG; Lim JY; Kim KH; Jeong SH
    Drug Dev Ind Pharm; 2015 Feb; 41(2):300-6. PubMed ID: 24502269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of irinotecan hydrochloride in aqueous solutions.
    Li WY; Koda RT
    Am J Health Syst Pharm; 2002 Mar; 59(6):539-44. PubMed ID: 11908247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pediatric oral solutions with propranolol hydrochloride for extemporaneous compounding: the formulation and stability study.
    Klovrzová S; Zahálka L; Matysová L; Horák P; Sklubalová Z
    Ceska Slov Farm; 2013 Feb; 62(1):35-9. PubMed ID: 23578266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T; Sandhu HK; Talele TT; Serajuddin AT
    Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preformulation studies of spironolactone: effect of pH, two buffer species, ionic strength, and temperature on stability.
    Pramar Y; Gupta VD
    J Pharm Sci; 1991 Jun; 80(6):551-3. PubMed ID: 1941547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A validated stability indicating ion-pair RP-LC method for zoledronic acid.
    Rao BM; Srinivasu MK; Rani ChP; kumar SS; Kumar PR; Chandrasekhar KB; Veerender M
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):781-90. PubMed ID: 15922532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An accurate prediction of the pH change due to degradation: correction for a "produced" secondary buffering system.
    Rosenberg LS; Hostetler CK; Wagenknecht DM; Aunet DA
    Pharm Res; 1988 Aug; 5(8):514-7. PubMed ID: 3244660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers.
    Eriksson JH; Hinrichs WL; de Jong GJ; Somsen GW; Frijlink HW
    Pharm Res; 2003 Sep; 20(9):1437-43. PubMed ID: 14567639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preformulation studies of acetazolamide: effect of pH, two buffer species, ionic strength, and temperature on its stability.
    Parasrampuria J; Gupta VD
    J Pharm Sci; 1989 Oct; 78(10):855-7. PubMed ID: 2600793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation.
    Wuchner K; Büchler J; Spycher R; Dalmonte P; Volkin DB
    J Pharm Sci; 2010 Aug; 99(8):3343-61. PubMed ID: 20229596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stabilization of eptifibatide by cosolvents.
    Zhao L; Yalkowsky SH
    Int J Pharm; 2001 May; 218(1-2):43-56. PubMed ID: 11337148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-dependent effect of magnesium sulfate on the stability of penicillin G potassium solution.
    Das Gupta V; Stewart KR
    Am J Hosp Pharm; 1985 Mar; 42(3):598-602. PubMed ID: 3985024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dynamic system for the simulation of fasting luminal pH-gradients using hydrogen carbonate buffers for dissolution testing of ionisable compounds.
    Garbacz G; Kołodziej B; Koziolek M; Weitschies W; Klein S
    Eur J Pharm Sci; 2014 Jan; 51():224-31. PubMed ID: 24095865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of ranitidine in injectable solutions.
    Vehabovic M; Hadzovic S; Stambolic F; Hadzic A; Vranjes E; Haracic E
    Int J Pharm; 2003 Apr; 256(1-2):109-15. PubMed ID: 12695016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of parenteral midazolam in an oral formulation.
    Walker SE; Grad HA; Haas DA; Mayer A
    Anesth Prog; 1997; 44(1):17-22. PubMed ID: 9481976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution stability of factor Xa inhibitors as a function of pH.
    Yang P; Macdonald F
    Drug Dev Ind Pharm; 2004; 30(9):967-73. PubMed ID: 15554221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preformulation, formulation, and in vivo efficacy of topically applied apomine.
    Kuehl PJ; Stratton SP; Powell MB; Myrdal PB
    Int J Pharm; 2009 Dec; 382(1-2):104-10. PubMed ID: 19699284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.